Public signalCompany raiseAuto-indexed · Unverified
Cantai Therapeutics, Inc. raised $550K
Cantai Therapeutics, Inc.· PHILADELPIA, US· Biotechnology· Filed Jul 15, 2025
Cantai Therapeutics, Inc. reported raising capital. Based in PHILADELPIA, PENNSYLVANIA, US. First sale reported 2025-07-02. Automatically indexed from a public SEC EDGAR Form D filing. Details beyond the filing have not been verified.
Raised
$550,000
Confidence90%
Raised
$550,000
Investors
3
Incorporated
2023
Jurisdiction
DELAWARE
On the record
- Location
- PHILADELPIA, US
- Sector
- Biotechnology
- Record type
- Company raise
- Stage
- Reported raised
- Amount raised
- $550,000
- Target amount
- $1.1M
- Filing date
- Jul 15, 2025
- Issuer type
- operating company
Gaps in the record
- Valuation and deal terms are not on the public record
- No company website on record
- Investors are not disclosed
- Not yet claimed or verified by the company
Filing details
- Jurisdiction of incorporation
- DELAWARE
- Year incorporated
- 2023
- Industry group
- Biotechnology
- Number of investors
- 3
- Includes non-accredited investors
- No
- Revenue range
- Decline to Disclose
- Total offering amount
- $1.1M
- Amendment
- No
People named on this filing
Officers, directors, managers and entities listed in the public filing.
Sources & provenance
“Operating company sold 550,000 USD under Reg D.”
View original filing (SEC EDGAR Form D)
Automatically indexed from SEC EDGAR Form D · filing dated Jul 15, 2025. Details beyond the filing have not been verified.
Tags
USCompanyBiotechnology$100K – $1MCompany Raise
Are you associated with Cantai Therapeutics, Inc.?
This is an automatically discovered public record, not a verified company listing. Founders can claim it and replace inferred data with verified facts.
Claim this record